Nanomechanics combined with HDX reveals allosteric drug binding sites of CFTR NBD1.
Computational And Structural Biotechnology Journal
Padányi, Rita R; Farkas, Bianka B; Tordai, Hedvig H; Kiss, Bálint B; Grubmüller, Helmut H; Soya, Naoto N; Lukács, Gergely L GL; Kellermayer, Miklós M; Hegedűs, Tamás T
Structure-guided combination therapy to potently improve the function of mutant CFTRs.
Nature Medicine
Veit, Guido G; Xu, Haijin H; Dreano, Elise E; Avramescu, Radu G RG; Bagdany, Miklos M; Beitel, Lenore K LK; Roldan, Ariel A; Hancock, Mark A MA; Lay, Cecilia C; Li, Wei W; Morin, Katelin K; Gao, Sandra S; Mak, Puiying A PA; Ainscow, Edward E; Orth, Anthony P AP; McNamara, Peter P; Edelman, Aleksander A; Frenkiel, Saul S; Matouk, Elias E; Sermet-Gaudelus, Isabelle I; Barnes, William G WG; Lukacs, Gergely L GL
Structural stability of purified human CFTR is systematically improved by mutations in nucleotide binding domain 1.
Biochimica Et Biophysica Acta. Biomembranes
Yang, Zhengrong Z; Hildebrandt, Ellen E; Jiang, Fan F; Aleksandrov, Andrei A AA; Khazanov, Netaly N; Zhou, Qingxian Q; An, Jianli J; Mezzell, Andrew T AT; Xavier, Bala M BM; Ding, Haitao H; Riordan, John R JR; Senderowitz, Hanoch H; Kappes, John C JC; Brouillette, Christie G CG; Urbatsch, Ina L IL
Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell.
Nature Communications
Bagdany, Miklos M; Veit, Guido G; Fukuda, Ryosuke R; Avramescu, Radu G RG; Okiyoneda, Tsukasa T; Baaklini, Imad I; Singh, Jay J; Sovak, Guy G; Xu, Haijin H; Apaja, Pirjo M PM; Sattin, Sara S; Beitel, Lenore K LK; Roldan, Ariel A; Colombo, Giorgio G; Balch, William W; Young, Jason C JC; Lukacs, Gergely L GL
Development and characterization of synthetic antibodies binding to the cystic fibrosis conductance regulator.
Mabs
Gakhal, Amandeep K AK; Jensen, Timothy J TJ; Bozoky, Zoltan Z; Roldan, Ariel A; Lukacs, Gergely L GL; Forman-Kay, Julie J; Riordan, John R JR; Sidhu, Sachdev S SS
Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy.
Protein Science : A Publication Of The Protein Society
Hall, Justin D JD; Wang, Hong H; Byrnes, Laura J LJ; Shanker, Suman S; Wang, Kelong K; Efremov, Ivan V IV; Chong, P Andrew PA; Forman-Kay, Julie D JD; Aulabaugh, Ann E AE
Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR.
The Journal Of Physiology
Xu, Zhe Z; Pissarra, Luísa S LS; Farinha, Carlos M CM; Liu, Jia J; Cai, Zhiwei Z; Thibodeau, Patrick H PH; Amaral, Margarida D MD; Sheppard, David N DN
VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1.
Molecular Biology Of The Cell
Ren, Hong Yu HY; Grove, Diane E DE; De La Rosa, Oxana O; Houck, Scott A SA; Sopha, Pattarawut P; Van Goor, Fredrick F; Hoffman, Beth J BJ; Cyr, Douglas M DM
Mechanism-based corrector combination restores ΔF508-CFTR folding and function.
Nature Chemical Biology
Okiyoneda, Tsukasa T; Veit, Guido G; Dekkers, Johanna F JF; Bagdany, Miklos M; Soya, Naoto N; Xu, Haijin H; Roldan, Ariel A; Verkman, Alan S AS; Kurth, Mark M; Simon, Agnes A; Hegedus, Tamas T; Beekman, Jeffrey M JM; Lukacs, Gergely L GL
Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect.
Human Molecular Genetics
Colas, Julien J; Faure, Grazyna G; Saussereau, Emilie E; Trudel, Stéphanie S; Rabeh, Wael M WM; Bitam, Sara S; Guerrera, Ida Chiara IC; Fritsch, Janine J; Sermet-Gaudelus, Isabelle I; Davezac, Noëlie N; Brouillard, Franck F; Lukacs, Gergely L GL; Herrmann, Harald H; Ollero, Mario M; Edelman, Aleksander A